disease invuinerable individuals.
It has been recognised since the study of Tomlinson et al (1968) that the neuropathological distinction between Alzheimer's disease (AD) and normal brain aging is quantitative rather than qualitative. In 1988, Katzman et a! (1988) described a group of 10 elderly individuals with neuropathologically diagnosed AD and preserved mental status during life. They concluded that these individuals â€oe¿ may have started with a larger brain and more large neurons and thus might be said to have had a greater reserveâ€•, which protected them from the clinical manifestation of the disease. Mean brain weight was higher and the number of large neurons in the frontal, parietal and temporal cortices greater in this group compared with clinically demented groups with or without pathological AD and a control group of nondemented persons with no AD pathology. If persons with larger brains have greater brain reserve, it should take them longer to accumulate a sufficient number of lesions to express clinical symptoms. Recently, Schofield ci a! (1995) estimated premorbid brain size using the average intracranial area of two adjacent CT scan sections and reported that the age of onset of disease in 28 women with probable AD was correlated 0.64 (P=0.01) with premorbid brain size when height, education and ethnic group were controlled.
The two studies that examined measures of brain size in relationship to the clinical expression of AD (Katmian ci a!, 1988; Schofield eta!, 1995) were based on relatively small, selected clinical samples. No study has yet examined this association in a population based epidemiological cohort. We hypothesised that a larger brain volume, indexed by greater head circumference, would offer a buffer against the clinical symptoms of AD, resultinginalowerrisk and reduced severity of disease. To address this question, we administered a cognitive screening test to a geogra phically defined population of 1985 elderly Japanese Americans for whom head circumference measure ments were obtained as part of the baseline exiuninn tion in a cohort study of the prevalenceand incidence of memory impairmentand its causes in the Japanese Scale for the Aged (Hasegawa, 1983) 
Clinical evaluation sample
Of those participating in Phase 1,450 (23%) were sampled from all strata of cognitive performance to receive a clinical evaluation. All persons were sampled who scored less than 81 of a possible 100 points on the CASI (n = 302); 33% of those scoring between 81 and 86.9 (n=91), and 4% of those scoring 87 + (is= 57) were sampled. Sampling probabilities were enriched for older persons so that controls would be of similar age to dementia cases. Of 450 samples, 382 (85%) completed the clinical and neuropsychological evaluations. Of these, 256 were from the low, 78 from the intermediate and 48 from the high CASI group. Data on years of education for this analysis were obtained from proxies when the participants were demented.
All participants in the clinical evaluation sample received a standardised neuropsychological screen ing battery that was administered by a trained psychometrician and interpreted by a geriatric neuropsychologist. They also received a complete physical and neurological exam by a neurologist or a geriatrician. Data on age of onset were gathered by the examining physician from the case's proxy informant. This variable was categorised into five groups: <6 months, 6 monthsâ€"iyear, 1â€"3 years, 3â€"5years and 5 or more years prior to examination.
Participants suspected of having dementia had laboratory evaluations including non-contrast CT scans of the brain, complete blood counts, cry throcyte sedimentation rates, blood chemistries, thyroid function tests, vitamin B12 levels and FTAâ€"ABSsyphilis serologies. The presence of dementia was determined by a consensus committee (Larson ci a!, 1990 ) consisting of a neurologist, a geriatrician, a neuropsychologist, an epidemiologist and a research nurse.
Dementia diagnoseswere made using DSM-IH-R criteria (American Psychiatric Association, 1987) . In the analyses below, AD cases were defined as those who met the definitions for probable or possible Alzheimer's disease by NINCDS-ADRDA criteria (McKhann eta!, 1984) and whose Clinical Dementia Rating (CDR Hughes ci a!, 1982) was I or higher. Fifty-two participants met criteria for probable AD and 31 for possible AD. Among the 382 persons sampled and diagnosed, controls were defined as those who were not demented by DSM-ffl-R and NINCDS-ADRDA criteria and whose CDR was 0 (is = 117). In analyses in which the entire Phase I cohort was included, controls were defined as all those who were not diagnosed with dementia, including those unsampled. Based on our prevalence study (Graves et a!, 1995), only an estimated 2.2 individuals from the unsampled cohort with avail able head circumference data (is= 1579) are expected to have a dementia of any type.
Statletical analysis
In order to examine differences in head size between individuals, we subtracted the minimum head 
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GRAVES E@AL circumference in the sample from each individual's measurement, yielding a head circumference differ ence score. Preliminary analyses indicated that this variable was related nonlinearly to CASI score. To make this relationship linear and to stabilise the nonconstant variance, a square root transformation was performed on the difference score, yielding a transformed head circumference (THC). Subsequent analyses used this variable (THC), which ranged from 0-3.90 as the primary measure of head circumference. The corresponding centi meter measurements were, for 0: 49.53cm, 1: 50.53cm, 2: 53.53cm, 3: 58.53cm and 4: 65.53cm.
Univariate and multiple linear regression were used to assess the relation between the transformed measure of head circumference and CASI score (Zar, 1984) . Logistic regression was performed to evaluate the odds of Alzheimer's disease associated with each unit increase in THC (Hosmer & Lemeshow, 1989) . Differences between subgroups were assessed by running separate multiple regres sion models and by introducing interaction terms in multiple regression models. Analyses were con ducted using SAS (1990) and SPSS-PC+ (1986).
Results Table 1 shows the characteristics of the baseline population by initial performance on the CASI. In general, the population was well educated (mean number of years of completed education, 12.7, median, 12.0). Women were slightly older than men (mean for women 73.5, s.d.=7.8; for men 72.2, s.d.=6.1, P<0.001). In Fig. 1 , the unadjusted association between mean CASI score and head circumference (in centimetres) is shown. The median head circumference in the cohort was 55.7cm. For persons with a head circumference greater than the median, there was little relation to Tabisi chacte.istics of the baselinepopulation(n1985), by CASI CASI performance. However, CASI scores fell sharply with decreasing head circumference below the median. The standard errors for the low mean head circumference measurements were larger than those on the higher end, due largely to the small number of individuals in these categories. Multiple regression analysis of the relation of age, gender and number of years of attained education to head circumference showed that in the cohort, female gender was the strongest predictor ($ (standardised regression coefficient)= â€"¿ 0.56, F=0.0000), fol lowed by lower education in years (fl= 0.09, P=0.000l) and increasing age in years (p=â€"¿ 0.08, P=0.0002).
To assess the association between head circum ference and cognitive performance, we ran multiple linear regression models in the baseline population, adjusting for age, sex and education. Unadjusted analysis of ThC in the cohort showed that each unit increase in THC was associated with an increase of 6.4 CASI points (95% CI: 4.8, 8.9; P=0.0000). After adjusting for age, gender and attained education, the parameter estimate de creased to 3.8 (95% CI: 2.3, 5.3; P=O.0000), but was still highly significant.
To evaluate whether THC was related not only to cognitive function but also to disease status, logistic regression models were constructed predicting probable AD from THC, using as controls all persons not diagnosed with AD. These analyses showed that while THC in the model alone predicted probable AD (unadjusted odds ratio (OR)=0.28, 95% CI: 0.16, 0.49), when adjusted for age, sex and years of attained education, there was no relation (OR for probable AD: 0.87 (95% CI: 0.33, 1.87)).
We then carried out a series of analyses of the THC-CASI relation among the 52 probable AD, 31 possible AD and 117 controls who received clinical assessment. The results are presented in Table 2 . After adjusting for age, sex and education, only the probable AD cases showed an association between smaller THC and lower CAST score (P<0.006). We also performed analyses adding an interaction term between probable AD and THC into the multiple regression model for the entire sample adjusting for age, sex and education. In this model, the parameter estimate @ was 3.5 (95% CI: â€"¿ 2.0, 9.0; P=0.2), @ 24.8 (95% CI: 12.1, 37.5; P= 0.0002) and @@ fortheir interaction â€"¿ 104.9 (95% CI: â€"¿ 134.5, â€"¿ 75.3; P=O.0000). Within the probable AD group, models were run to determine whether gender, educational level and age modified the effect of head circumference on CAST score. These parameters were not Head cIrcumference(cm) established. Our results remain to be replicated in other populations.
Interpretation
The association between head circumference and the severity of AD in a cross-sectional study could occur in at least two ways. First, persons with smaller head circumference may have expressed symptoms at an earlier age than those with larger head circumference and therefore have had a longer duration of disease by the time they were examined. Second, the disease course among persons with smaller head circumferences may be more rapid than in those with larger circumferences. In support of the first explanation, Schofield et a! (1995) found that among 28 women with probable AD, those with smaller intracranial areas measured by CT scan had an earlier age of onset than those with larger areas. In an attempt to confirm this finding, we examined the association between THC and the age of onset of dementia. Since age of onset is highly correlated with age, and because brain and statistically significant (P@@= 0.45; @ =0.42; P@c,@=0.l2).
Discussion
We found that head circumference, a correlate of initial brain size, predicted the severity of cognitive impairment in Alzheimer's disease in this popula tion. Our findings indicate that patients with probable AD who have smaller head circumfer ences have lower scores on a global cognitive test (the CASI) than those with larger head circumfer ences. By contrast, we found no association between head circumference and performance on the CASI in individuals meeting criteria for possible AD or in normal controls. Head circumference also was not an independent risk factor for prevalent AD. These findings suggest that while the initial size of the brain is likely to be irrelevant to the cognitive status of individuals without an ongoing Alzheimer pathological process, it may be important in determining reserve capacity which can modify the clinical presentation of that process, once it is well
Table2
Resultsfor the relationbetween transformed head circumferenceffHC) and CAStscore, una4ustod and a4usted forage, gender and years of education, for probable and possibleAD cases and controls head circumference, along with body height and weight, have markedly increased over the course of the century (Miller & Corsellis, 1977) , this analysis showed the reverse trend of that expected. We therefore computed duration of disease by sub tracting age of onset from age at the clinical examination. Although there was a trend for persons with larger head circumference to have the disease for a shorter amount of time, this was not statistically significant (P=0.29). However, our analyses may be confounded by persons with smaller head circumference (who are generally shorter and lighter) experiencing increased early mortality relative to taller, larger headed persons (Elo & Preston, 1992) . The average age of cases in the study of Schofield et a! was 73; in the present study, it was 89.4. Given this age difference, the results of the present study will be impacted to a greater extent by selective mortality. We also note that the measurement of age of onset is likely to be imprecise in prevalence studies, which also could contribute to the inconclusive results of the age of onset analyses. It also is possible that the rapidity of the disease course varies for persons with small and large head circumference. This has not been previously ad dressed in the literature. However, the association between lower education and disease course has been examined. Insofar as there is a relationship between head circumference and attained education (in the present study the simple correlation between these variables was 0.22 (P<0.001)), the results are equivocal, with some community-based studies showing a more rapid course among subjects with lower education (Evans et a!, 1993) and others a more rapid course among those with a higher education (Teri et a!, 1995) .
In this study, the association between head circumference and cognitive impairment was in tially examined because we suspected that the association found in numerous community-based studies between lower education and increased prevalence and incidence of dementia and Alzheimer's disease (Zhang et a!, 1990; Mortimer & Graves, 1993; Stern et a!, 1994) could be due to an association between lower education and reduced brain development. In our study, neither education nor head circumference were risk factors for prevalent dementia or Alzheimer's disease after adjusting for confounders. By contrast, FÃ ¶rstI et a! (1991) reported intracranial size from CT scan measurements to be significantly smaller among AD patients compared with age and sex-matched controls. Because individuals with Alzheimer's disease and small head circumferences may experi ence reduced survival compared with both non demented persons with small head circumferences and AD patients with large head circumferences, prospective data are needed to determine whether head circumference is a risk factor for incident disease and whether it is related to age of onset.
Methodological lames
In the analyses reported above, we did not adjust for height or weight, because we were interested in examining brain size as measured by head circum ference. We also were unable to measure height in many of the prevalent cases due to the severity of the disease. However, we were able to obtain weight in most cases. Height and weight were strongly correlated in the controls (r= 0.71, P=0.000). Among probable AD cases, the results of analyses of the THC-CASI association adjusted for weight retained statistical significance (P=0.03), while the parameter for weight was not significant (P=0.20). In another analysis of 1623 participants in the population in which prevalent dementia cases were removed, we found that head circumference predicted CAST score after adjusting for age, gender, education (in years) and body mass index (weight/height squared). However, this association was small (b= 1.24, P=0.003) and may be generated by new cases in the population. Thus, it is unlikely that the association between THC and severity of cognitive impairment in AD found in this study is due to associations with other indicators of growth.
Since head circumferencewas used as a surrogate measure of brein volume, it may be argued that this estimate is, at best, imperfect. Head size has been correlated with brain volume at 0.5-0.8 (van Valen, 1974; Brandt, 1978; Jensen & Sinha, 1993) . Non differential measurement error of this type results in an attenuation of the true effect. Therefore, the actual protection afforded by greater brain reserve may be stronger than that found in this study.
Public health Implicatlam
Brain growth is known to occur predominantly during the latter part of gestation and the first two to three years of life (Dobbing & Sands, 1973; Epstein, 1979; Andreasen et a!, 1993 
